PTC Therapeutics, Inc.
PTCT
$46.39
$0.380.83%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 1,046.28% | 57.71% | 19.79% | 50.13% | 34.10% |
| Total Depreciation and Amortization | -86.96% | -91.62% | -89.55% | -86.24% | 29.35% |
| Total Amortization of Deferred Charges | 1.01% | 2.68% | -47.64% | -47.60% | -32.42% |
| Total Other Non-Cash Items | -7.38% | -113.60% | -73.00% | -68.66% | 49.64% |
| Change in Net Operating Assets | -164.24% | 144.28% | 30.99% | -134.51% | 69.21% |
| Cash from Operations | 1,129.64% | 70.08% | -430.28% | -406.04% | 339.94% |
| Capital Expenditure | 82.02% | 32.32% | 91.79% | 218.09% | 6.64% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -73.44% | 405.54% | -81.47% | -478.83% | -463.31% |
| Cash from Investing | -60.41% | 383.54% | -44.19% | -177.55% | -296.71% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | -- | -- | -8.05% |
| Issuance of Common Stock | 675.91% | 994.75% | -83.37% | -74.61% | -64.10% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -100.00% | -21,311.76% | 1,612,046.67% | -- |
| Cash from Financing | 1,642.59% | -95.73% | -624.46% | 1,235.22% | -86.81% |
| Foreign Exchange rate Adjustments | 365.67% | -379.58% | 466.30% | -150.29% | 74.51% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,634.23% | -40.42% | -198.83% | 1,242.22% | 26.74% |